nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—NFATC1—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.0274	0.055	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.0232	0.0465	CbGpPWpGaD
Pseudoephedrine—NFATC1—Heart Development—BMP4—Barrett's esophagus	0.0209	0.0419	CbGpPWpGaD
Pseudoephedrine—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.018	0.0359	CcSEcCtD
Pseudoephedrine—Blood pressure increased—Omeprazole—Barrett's esophagus	0.018	0.0359	CcSEcCtD
Pseudoephedrine—Lightheadedness—Omeprazole—Barrett's esophagus	0.0161	0.0321	CcSEcCtD
Pseudoephedrine—Lightheadedness—Esomeprazole—Barrett's esophagus	0.0161	0.0321	CcSEcCtD
Pseudoephedrine—Irritability—Esomeprazole—Barrett's esophagus	0.0125	0.0249	CcSEcCtD
Pseudoephedrine—Irritability—Omeprazole—Barrett's esophagus	0.0125	0.0249	CcSEcCtD
Pseudoephedrine—Angina pectoris—Esomeprazole—Barrett's esophagus	0.011	0.0219	CcSEcCtD
Pseudoephedrine—Angina pectoris—Omeprazole—Barrett's esophagus	0.011	0.0219	CcSEcCtD
Pseudoephedrine—Dysuria—Omeprazole—Barrett's esophagus	0.0106	0.0211	CcSEcCtD
Pseudoephedrine—Dysuria—Esomeprazole—Barrett's esophagus	0.0106	0.0211	CcSEcCtD
Pseudoephedrine—NFATC1—Calcium signaling in the CD4+ TCR pathway—PTGS2—Barrett's esophagus	0.00996	0.02	CbGpPWpGaD
Pseudoephedrine—NFATC1—Initiation of transcription and translation elongation at the HIV-1 LTR—RELA—Barrett's esophagus	0.00947	0.019	CbGpPWpGaD
Pseudoephedrine—Bradycardia—Omeprazole—Barrett's esophagus	0.0092	0.0184	CcSEcCtD
Pseudoephedrine—Bradycardia—Esomeprazole—Barrett's esophagus	0.0092	0.0184	CcSEcCtD
Pseudoephedrine—Hallucination—Esomeprazole—Barrett's esophagus	0.00899	0.0179	CcSEcCtD
Pseudoephedrine—Hallucination—Omeprazole—Barrett's esophagus	0.00899	0.0179	CcSEcCtD
Pseudoephedrine—NFATC1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—Barrett's esophagus	0.00876	0.0176	CbGpPWpGaD
Pseudoephedrine—IL2—Calcium signaling in the CD4+ TCR pathway—PTGS2—Barrett's esophagus	0.00842	0.0169	CbGpPWpGaD
Pseudoephedrine—NFATC1—Ectoderm Differentiation—BMP4—Barrett's esophagus	0.00837	0.0168	CbGpPWpGaD
Pseudoephedrine—NFATC1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.00819	0.0164	CbGpPWpGaD
Pseudoephedrine—NFATC1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—Barrett's esophagus	0.00795	0.0159	CbGpPWpGaD
Pseudoephedrine—Tension—Omeprazole—Barrett's esophagus	0.00772	0.0154	CcSEcCtD
Pseudoephedrine—Tension—Esomeprazole—Barrett's esophagus	0.00772	0.0154	CcSEcCtD
Pseudoephedrine—Nervousness—Omeprazole—Barrett's esophagus	0.00764	0.0152	CcSEcCtD
Pseudoephedrine—Nervousness—Esomeprazole—Barrett's esophagus	0.00764	0.0152	CcSEcCtD
Pseudoephedrine—Muscle spasms—Omeprazole—Barrett's esophagus	0.00757	0.0151	CcSEcCtD
Pseudoephedrine—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00757	0.0151	CcSEcCtD
Pseudoephedrine—Tremor—Esomeprazole—Barrett's esophagus	0.00737	0.0147	CcSEcCtD
Pseudoephedrine—Tremor—Omeprazole—Barrett's esophagus	0.00737	0.0147	CcSEcCtD
Pseudoephedrine—Agitation—Omeprazole—Barrett's esophagus	0.00723	0.0144	CcSEcCtD
Pseudoephedrine—Agitation—Esomeprazole—Barrett's esophagus	0.00723	0.0144	CcSEcCtD
Pseudoephedrine—IL2—IL23-mediated signaling events—RELA—Barrett's esophagus	0.00713	0.0143	CbGpPWpGaD
Pseudoephedrine—IL2—IL2 signaling events mediated by PI3K—RELA—Barrett's esophagus	0.00713	0.0143	CbGpPWpGaD
Pseudoephedrine—Vertigo—Omeprazole—Barrett's esophagus	0.00707	0.0141	CcSEcCtD
Pseudoephedrine—Vertigo—Esomeprazole—Barrett's esophagus	0.00707	0.0141	CcSEcCtD
Pseudoephedrine—Palpitations—Esomeprazole—Barrett's esophagus	0.00695	0.0139	CcSEcCtD
Pseudoephedrine—Palpitations—Omeprazole—Barrett's esophagus	0.00695	0.0139	CcSEcCtD
Pseudoephedrine—IL2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.00692	0.0139	CbGpPWpGaD
Pseudoephedrine—Hypertension—Omeprazole—Barrett's esophagus	0.00679	0.0136	CcSEcCtD
Pseudoephedrine—Hypertension—Esomeprazole—Barrett's esophagus	0.00679	0.0136	CcSEcCtD
Pseudoephedrine—Chest pain—Esomeprazole—Barrett's esophagus	0.0067	0.0134	CcSEcCtD
Pseudoephedrine—Chest pain—Omeprazole—Barrett's esophagus	0.0067	0.0134	CcSEcCtD
Pseudoephedrine—Anxiety—Esomeprazole—Barrett's esophagus	0.00668	0.0133	CcSEcCtD
Pseudoephedrine—Anxiety—Omeprazole—Barrett's esophagus	0.00668	0.0133	CcSEcCtD
Pseudoephedrine—Confusional state—Omeprazole—Barrett's esophagus	0.00648	0.0129	CcSEcCtD
Pseudoephedrine—Confusional state—Esomeprazole—Barrett's esophagus	0.00648	0.0129	CcSEcCtD
Pseudoephedrine—NFATC1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Barrett's esophagus	0.00644	0.0129	CbGpPWpGaD
Pseudoephedrine—Tachycardia—Omeprazole—Barrett's esophagus	0.00627	0.0125	CcSEcCtD
Pseudoephedrine—Tachycardia—Esomeprazole—Barrett's esophagus	0.00627	0.0125	CcSEcCtD
Pseudoephedrine—NFATC1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.00625	0.0125	CbGpPWpGaD
Pseudoephedrine—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00621	0.0124	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00621	0.0124	CcSEcCtD
Pseudoephedrine—NFATC1—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.00614	0.0123	CbGpPWpGaD
Pseudoephedrine—Anorexia—Esomeprazole—Barrett's esophagus	0.00612	0.0122	CcSEcCtD
Pseudoephedrine—Anorexia—Omeprazole—Barrett's esophagus	0.00612	0.0122	CcSEcCtD
Pseudoephedrine—Insomnia—Omeprazole—Barrett's esophagus	0.00581	0.0116	CcSEcCtD
Pseudoephedrine—Insomnia—Esomeprazole—Barrett's esophagus	0.00581	0.0116	CcSEcCtD
Pseudoephedrine—Dyspnoea—Omeprazole—Barrett's esophagus	0.00573	0.0114	CcSEcCtD
Pseudoephedrine—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00573	0.0114	CcSEcCtD
Pseudoephedrine—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00565	0.0113	CcSEcCtD
Pseudoephedrine—Dyspepsia—Omeprazole—Barrett's esophagus	0.00565	0.0113	CcSEcCtD
Pseudoephedrine—TNF—Apoptosis—MCL1—Barrett's esophagus	0.00565	0.0113	CbGpPWpGaD
Pseudoephedrine—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00558	0.0111	CcSEcCtD
Pseudoephedrine—Decreased appetite—Omeprazole—Barrett's esophagus	0.00558	0.0111	CcSEcCtD
Pseudoephedrine—TNF—TGF-beta Receptor Signaling—BMP4—Barrett's esophagus	0.00558	0.0112	CbGpPWpGaD
Pseudoephedrine—Pain—Omeprazole—Barrett's esophagus	0.00549	0.011	CcSEcCtD
Pseudoephedrine—Pain—Esomeprazole—Barrett's esophagus	0.00549	0.011	CcSEcCtD
Pseudoephedrine—IL2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Barrett's esophagus	0.00545	0.0109	CbGpPWpGaD
Pseudoephedrine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00529	0.0106	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00529	0.0106	CcSEcCtD
Pseudoephedrine—IL2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.00528	0.0106	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.00526	0.0106	CbGpPWpGaD
Pseudoephedrine—NFATC1—BCR signaling pathway—RELA—Barrett's esophagus	0.00524	0.0105	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—HGF—Barrett's esophagus	0.00522	0.0105	CbGpPWpGaD
Pseudoephedrine—MAOA—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00521	0.0104	CbGpPWpGaD
Pseudoephedrine—Body temperature increased—Omeprazole—Barrett's esophagus	0.00508	0.0101	CcSEcCtD
Pseudoephedrine—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00508	0.0101	CcSEcCtD
Pseudoephedrine—TNF—Transcription factor regulation in adipogenesis—PPARG—Barrett's esophagus	0.00497	0.00996	CbGpPWpGaD
Pseudoephedrine—IL2—IL12-mediated signaling events—RELA—Barrett's esophagus	0.00485	0.00972	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.00477	0.00957	CbGpPWpGaD
Pseudoephedrine—Asthenia—Omeprazole—Barrett's esophagus	0.00461	0.00919	CcSEcCtD
Pseudoephedrine—Asthenia—Esomeprazole—Barrett's esophagus	0.00461	0.00919	CcSEcCtD
Pseudoephedrine—IL2—Folate Metabolism—RELA—Barrett's esophagus	0.00449	0.009	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.00446	0.00895	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.00445	0.00892	CbGpPWpGaD
Pseudoephedrine—TNF—Overview of nanoparticle effects—PTGS2—Barrett's esophagus	0.0044	0.00881	CbGpPWpGaD
Pseudoephedrine—TNF—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00435	0.00872	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.0043	0.00862	CbGpPWpGaD
Pseudoephedrine—TNF—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.00426	0.00855	CbGpPWpGaD
Pseudoephedrine—Dizziness—Omeprazole—Barrett's esophagus	0.00425	0.00847	CcSEcCtD
Pseudoephedrine—Dizziness—Esomeprazole—Barrett's esophagus	0.00425	0.00847	CcSEcCtD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.0042	0.00843	CbGpPWpGaD
Pseudoephedrine—NFATC1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.00414	0.0083	CbGpPWpGaD
Pseudoephedrine—Vomiting—Omeprazole—Barrett's esophagus	0.00408	0.00815	CcSEcCtD
Pseudoephedrine—Vomiting—Esomeprazole—Barrett's esophagus	0.00408	0.00815	CcSEcCtD
Pseudoephedrine—Rash—Omeprazole—Barrett's esophagus	0.00405	0.00808	CcSEcCtD
Pseudoephedrine—Rash—Esomeprazole—Barrett's esophagus	0.00405	0.00808	CcSEcCtD
Pseudoephedrine—Dermatitis—Omeprazole—Barrett's esophagus	0.00405	0.00807	CcSEcCtD
Pseudoephedrine—Dermatitis—Esomeprazole—Barrett's esophagus	0.00405	0.00807	CcSEcCtD
Pseudoephedrine—IL2—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.00404	0.00809	CbGpPWpGaD
Pseudoephedrine—Headache—Omeprazole—Barrett's esophagus	0.00402	0.00803	CcSEcCtD
Pseudoephedrine—Headache—Esomeprazole—Barrett's esophagus	0.00402	0.00803	CcSEcCtD
Pseudoephedrine—ADRB2—Arf6 signaling events—HGF—Barrett's esophagus	0.00395	0.00791	CbGpPWpGaD
Pseudoephedrine—TNF—EBV LMP1 signaling—RELA—Barrett's esophagus	0.00388	0.00778	CbGpPWpGaD
Pseudoephedrine—TNF—Canonical NF-kappaB pathway—RELA—Barrett's esophagus	0.00388	0.00778	CbGpPWpGaD
Pseudoephedrine—Nausea—Omeprazole—Barrett's esophagus	0.00381	0.00761	CcSEcCtD
Pseudoephedrine—Nausea—Esomeprazole—Barrett's esophagus	0.00381	0.00761	CcSEcCtD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.00377	0.00757	CbGpPWpGaD
Pseudoephedrine—IL2—Allograft Rejection—CXCL8—Barrett's esophagus	0.00366	0.00735	CbGpPWpGaD
Pseudoephedrine—TNF—EBV LMP1 signaling—CXCL8—Barrett's esophagus	0.00366	0.00734	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—CYP26A1—Barrett's esophagus	0.00365	0.00731	CbGpPWpGaD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.00356	0.00713	CbGpPWpGaD
Pseudoephedrine—IL2—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.00344	0.0069	CbGpPWpGaD
Pseudoephedrine—IL2—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.00324	0.0065	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—RELA—Barrett's esophagus	0.00303	0.00607	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.00294	0.0059	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—TP53—Barrett's esophagus	0.00293	0.00587	CbGpPWpGaD
Pseudoephedrine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—RELA—Barrett's esophagus	0.00291	0.00583	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.0028	0.00561	CbGpPWpGaD
Pseudoephedrine—MAOA—Biological oxidations—CYP26A1—Barrett's esophagus	0.00277	0.00555	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—BMP4—Barrett's esophagus	0.00276	0.00554	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00276	0.00553	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.00274	0.0055	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.00266	0.00533	CbGpPWpGaD
Pseudoephedrine—TNF—IL23-mediated signaling events—RELA—Barrett's esophagus	0.00265	0.00532	CbGpPWpGaD
Pseudoephedrine—IL2—Folate Metabolism—TP53—Barrett's esophagus	0.0026	0.00521	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.00258	0.00517	CbGpPWpGaD
Pseudoephedrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.00258	0.00517	CbGpPWpGaD
Pseudoephedrine—NFATC1—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.00253	0.00507	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—TP53—Barrett's esophagus	0.00248	0.00497	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.00244	0.00488	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.00241	0.00483	CbGpPWpGaD
Pseudoephedrine—TNF—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.0024	0.00481	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.00235	0.00471	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by WNT in cancer—APC—Barrett's esophagus	0.00235	0.00471	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00227	0.00454	CbGpPWpGaD
Pseudoephedrine—TNF—TNF receptor signaling pathway —RELA—Barrett's esophagus	0.00223	0.00447	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.00223	0.00447	CbGpPWpGaD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.00218	0.00438	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.00217	0.00434	CbGpPWpGaD
Pseudoephedrine—TNF—Ceramide signaling pathway—RELA—Barrett's esophagus	0.00216	0.00432	CbGpPWpGaD
Pseudoephedrine—TNF—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.00209	0.00418	CbGpPWpGaD
Pseudoephedrine—TNF—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.00205	0.00412	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.00203	0.00407	CbGpPWpGaD
Pseudoephedrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Barrett's esophagus	0.00203	0.00406	CbGpPWpGaD
Pseudoephedrine—TNF—Signaling events mediated by HDAC Class I—PPARG—Barrett's esophagus	0.00197	0.00395	CbGpPWpGaD
Pseudoephedrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.00197	0.00394	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—GAST—Barrett's esophagus	0.00196	0.00394	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by Wnt—APC—Barrett's esophagus	0.00194	0.00388	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.00193	0.00386	CbGpPWpGaD
Pseudoephedrine—TNF—Transcriptional regulation of white adipocyte differentiation—PPARG—Barrett's esophagus	0.00182	0.00366	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—GAST—Barrett's esophagus	0.00178	0.00357	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—HGF—Barrett's esophagus	0.00177	0.00354	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—GAST—Barrett's esophagus	0.00175	0.00351	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—RELA—Barrett's esophagus	0.00167	0.00335	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TP53—Barrett's esophagus	0.00163	0.00327	CbGpPWpGaD
Pseudoephedrine—TNF—Signaling events mediated by HDAC Class I—RELA—Barrett's esophagus	0.00159	0.0032	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00156	0.00314	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—HGF—Barrett's esophagus	0.00152	0.00305	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—HGF—Barrett's esophagus	0.00152	0.00304	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.0015	0.00301	CbGpPWpGaD
Pseudoephedrine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—Barrett's esophagus	0.0015	0.00301	CbGpPWpGaD
Pseudoephedrine—TNF—Transcriptional regulation of white adipocyte differentiation—RELA—Barrett's esophagus	0.00148	0.00296	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.00145	0.00292	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CDKN2A—Barrett's esophagus	0.00143	0.00287	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	0.00141	0.00283	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—RELA—Barrett's esophagus	0.00138	0.00276	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—CXCL8—Barrett's esophagus	0.00136	0.00273	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—SLC9A1—Barrett's esophagus	0.00136	0.00273	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—HGF—Barrett's esophagus	0.00135	0.0027	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—SST—Barrett's esophagus	0.00135	0.0027	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.00133	0.00267	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.00133	0.00266	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.00129	0.00259	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00125	0.0025	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—GAST—Barrett's esophagus	0.00124	0.0025	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—SST—Barrett's esophagus	0.00122	0.00245	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.0012	0.00241	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—PPARG—Barrett's esophagus	0.0012	0.00241	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00119	0.00238	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.00118	0.00236	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.00111	0.00223	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.0011	0.00221	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—APC—Barrett's esophagus	0.00108	0.00217	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—GAST—Barrett's esophagus	0.00105	0.00211	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.00102	0.00204	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000989	0.00198	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000981	0.00197	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—PPARG—Barrett's esophagus	0.00098	0.00197	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—Barrett's esophagus	0.000966	0.00194	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00096	0.00192	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HGF—Barrett's esophagus	0.00094	0.00189	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—RELA—Barrett's esophagus	0.000937	0.00188	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—SST—Barrett's esophagus	0.000928	0.00186	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000921	0.00185	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000916	0.00184	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000914	0.00183	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000868	0.00174	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SST—Barrett's esophagus	0.000853	0.00171	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—Barrett's esophagus	0.000837	0.00168	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—Barrett's esophagus	0.000797	0.0016	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HGF—Barrett's esophagus	0.000795	0.00159	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000794	0.00159	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000791	0.00159	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000764	0.00153	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000751	0.00151	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—SST—Barrett's esophagus	0.000747	0.0015	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000737	0.00148	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—SST—Barrett's esophagus	0.000731	0.00147	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SST—Barrett's esophagus	0.000722	0.00145	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000694	0.00139	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000694	0.00139	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000676	0.00136	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—APC—Barrett's esophagus	0.000645	0.00129	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—Barrett's esophagus	0.000636	0.00128	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGES—Barrett's esophagus	0.000624	0.00125	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—GAST—Barrett's esophagus	0.000616	0.00124	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—Barrett's esophagus	0.000607	0.00122	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—SST—Barrett's esophagus	0.000604	0.00121	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—GAST—Barrett's esophagus	0.000603	0.00121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—SST—Barrett's esophagus	0.000562	0.00113	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—GAST—Barrett's esophagus	0.000559	0.00112	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—GAST—Barrett's esophagus	0.000547	0.0011	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—RELA—Barrett's esophagus	0.000546	0.00109	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000524	0.00105	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—Barrett's esophagus	0.000509	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GAST—Barrett's esophagus	0.000498	0.000999	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTGS2—Barrett's esophagus	0.000489	0.000982	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—Barrett's esophagus	0.000488	0.000978	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000476	0.000954	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CYP26A1—Barrett's esophagus	0.000473	0.000948	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GAST—Barrett's esophagus	0.000463	0.000928	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—RELA—Barrett's esophagus	0.000461	0.000925	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—Barrett's esophagus	0.000459	0.00092	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.000457	0.000917	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GAST—Barrett's esophagus	0.000453	0.000907	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—APC—Barrett's esophagus	0.000451	0.000905	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—SST—Barrett's esophagus	0.000422	0.000846	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GAST—Barrett's esophagus	0.00042	0.000843	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGES—Barrett's esophagus	0.000417	0.000836	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—SST—Barrett's esophagus	0.000413	0.000828	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000413	0.000828	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—PPARG—Barrett's esophagus	0.000412	0.000827	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—SST—Barrett's esophagus	0.000383	0.000769	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000382	0.000766	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—APC—Barrett's esophagus	0.000382	0.000766	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—SST—Barrett's esophagus	0.000375	0.000752	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000374	0.00075	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000361	0.000725	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HGF—Barrett's esophagus	0.000358	0.000717	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—RELA—Barrett's esophagus	0.000353	0.000707	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—SST—Barrett's esophagus	0.000342	0.000685	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SLC9A1—Barrett's esophagus	0.000341	0.000684	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—RELA—Barrett's esophagus	0.000334	0.000669	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCL8—Barrett's esophagus	0.000332	0.000667	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GAST—Barrett's esophagus	0.00033	0.000663	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GAST—Barrett's esophagus	0.000323	0.000648	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—SST—Barrett's esophagus	0.000317	0.000636	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP26A1—Barrett's esophagus	0.000316	0.000634	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—SST—Barrett's esophagus	0.00031	0.000622	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000309	0.00062	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RELA—Barrett's esophagus	0.000298	0.000598	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000291	0.000584	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—SST—Barrett's esophagus	0.000288	0.000578	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000287	0.000576	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000285	0.000571	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCL8—Barrett's esophagus	0.000281	0.000564	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGES—Barrett's esophagus	0.000272	0.000545	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GAST—Barrett's esophagus	0.000267	0.000536	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GAST—Barrett's esophagus	0.000248	0.000498	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000235	0.000472	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC9A1—Barrett's esophagus	0.000228	0.000457	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SST—Barrett's esophagus	0.000226	0.000454	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SST—Barrett's esophagus	0.000222	0.000444	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000219	0.000439	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	0.000206	0.000413	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—Barrett's esophagus	0.000204	0.000409	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SST—Barrett's esophagus	0.000183	0.000367	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—Barrett's esophagus	0.000173	0.000346	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SST—Barrett's esophagus	0.00017	0.000341	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000164	0.00033	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000161	0.000323	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PPARG—Barrett's esophagus	0.000156	0.000312	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000149	0.000299	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	0.000148	0.000298	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000146	0.000293	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000133	0.000267	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000124	0.000248	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—Barrett's esophagus	0.000122	0.000245	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000121	0.000242	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—Barrett's esophagus	0.00012	0.000241	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APC—Barrett's esophagus	0.00012	0.00024	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APC—Barrett's esophagus	0.000117	0.000235	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000112	0.000225	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARG—Barrett's esophagus	0.000104	0.000208	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APC—Barrett's esophagus	9.69e-05	0.000194	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RELA—Barrett's esophagus	9.36e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RELA—Barrett's esophagus	9.16e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APC—Barrett's esophagus	9.01e-05	0.000181	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—Barrett's esophagus	8.82e-05	0.000177	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—Barrett's esophagus	8.63e-05	0.000173	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—Barrett's esophagus	8.18e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RELA—Barrett's esophagus	7.57e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—Barrett's esophagus	7.14e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RELA—Barrett's esophagus	7.04e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARG—Barrett's esophagus	6.77e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—Barrett's esophagus	6.63e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—Barrett's esophagus	5.41e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	5.33e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—Barrett's esophagus	5.3e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—Barrett's esophagus	4.38e-05	8.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—Barrett's esophagus	4.07e-05	8.16e-05	CbGpPWpGaD
